Debanjana Chatterjee Analyst PerformanceAnalyst at JonesTradingDebanjana Chatterjee is a stock analyst at JonesTrading focused in the medical sector, covering 12 publicly traded companies. Over the past year, Debanjana Chatterjee has issued 14 stock ratings, including strong buy, buy, and hold recommendations. While full access to Debanjana Chatterjee's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Debanjana Chatterjee's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings18 Last 1 YearsBuy Recommendations88.89% 16 Buy RatingsCompanies Covered12 Unique Companies Ratings Distribution18RatingsDistribution of strong buy, buy, hold, and sell ratings by Debanjana Chatterjee.RatingPercentageCount Strong Buy16.7%3 ratings Buy72.2%13 ratings Hold11.1%2 ratings Sell0.0%0 ratingsOut of 18 total stock ratings issued by Debanjana Chatterjee at JonesTrading, the majority (72.2%) have been Buy recommendations, followed by 16.7% Strong Buy and 11.1% Hold.Best & Worst CallsBest Call000.0%CTNMMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%SGMTJun 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ91.7% of companies on NASDAQ11 companiesNYSEAMERICAN8.3% of companies on NYSEAMERICAN1 companyDebanjana Chatterjee, an analyst at JonesTrading, currently covers 12 companies listed on NASDAQ and NYSEAMERICAN, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical11 companies91.7%Manufacturing1 company8.3%Debanjana Chatterjee of JonesTrading specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE9 companies75.0%MED - DRUGS2 companies16.7%PHARMACEUTICAL PREPARATIONS1 company8.3% Debanjana Chatterjee's Ratings History at JonesTrading Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsATHEAlterity Therapeutics6/30/2026Initiated Coverage$5.05$16.00Buy$0.0000.00% ROITBPHTheravance Biopharma6/29/2026Downgrade$17.19Hold$0.0000.00% ROISIONSionna Therapeutics4/28/2026Boost Price Target$39.91$63.00Buy$0.0000.00% ROISYRESpyre Therapeutics4/17/2026Boost Price Target$72.72$95.00Buy$0.0000.00% ROIHYFTMindWalk4/16/2026Initiated Coverage$1.31$5.00Buy$0.0000.00% ROIHYFTMindWalk4/15/2026Upgrade$1.32Strong-Buy$0.0000.00% ROIABCLAbCellera Biologics4/10/2026Initiated Coverage$3.44$11.00Buy$0.0000.00% ROIABCLAbCellera Biologics4/9/2026Upgrade$3.54Strong-Buy$0.0000.00% ROITRVITrevi Therapeutics3/19/2026Lower Price Target$10.67$24.00Buy$0.0000.00% ROINTLAIntellia Therapeutics3/4/2026Upgrade$13.60$29.00Buy$0.0000.00% ROIARMPArmata Pharmaceuticals1/5/2026Initiated Coverage$6.53$15.00Buy$0.0000.00% ROISYRESpyre Therapeutics12/1/2025Upgrade$30.05$64.00Buy$0.0000.00% ROINTLAIntellia Therapeutics11/11/2025Downgrade$10.06Hold$0.0000.00% ROISIONSionna Therapeutics9/8/2025Initiated Coverage$23.16$46.00Buy$0.0000.00% ROITBPHTheravance Biopharma6/17/2025Upgrade$10.75$24.00Strong-Buy$00.0000.00% ROISGMTSagimet Biosciences6/6/2025Boost Price Target$5.47$27.00Buy$0.0000.00% ROIKALVKalVista Pharmaceuticals3/26/2025Reiterated Rating$12.50$30.00Buy$00.0000.00% ROICTNMContineum Therapeutics3/13/2025Initiated Coverage$7.04$23.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyRoyal Bank Of CanadaWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupDeutsche Bank AktiengesellschaftRaymond James FinancialBMO Capital MarketsNational Bank FinancialBerenberg Bank Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
